Gamida Cell Ltd. logo

Gamida Cell Ltd.

Working to turn cells into powerful therapeutics for patients with cancer.

93 employees · est. 1998 · Boston, United States

VS
NexImmune, Inc. logo

NexImmune, Inc.

NexImmune, Directing T cell function to restore natural immunity

32 employees · est. 2011 · Gaithersburg, United States

Gamida Cell Ltd. is the older company (1998 vs 2011); Gamida Cell Ltd. is the larger of the two.

Side-by-Side Comparison

Gamida Cell Ltd. NexImmune, Inc.
Founded
1998 older 2011
Headquarters
Boston, United States Gaithersburg, United States
Employees
93 larger 32
Industry
Biotechnology, Health Care, Health and Wellness Biopharma, Biotechnology, Health and Wellness
Funding Stage
Post Ipo Debt Post Ipo Equity
Total Funding
$292.51M $87.44M
Funding Rounds
13 6
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Cell Therapy, Biopharmaceutical, NAM Technology, Cancer Treatment, Stem Cell Transplant, NK Cell Therapy, Hematologic Diseases, Blood Cancers, Drug Development, FDA Approval, Clinical Studies, Allogeneic Cell Sources Immunotherapy, T Cell Immunotherapies, Cancer Treatment, Clinical Stage, Proprietary Technology, AIM Technology, Oncology, Autoimmune Disorders, Pharmaceutical Company, Immuno-therapeutics, Artificial Immune Modulation, Nanoparticles, Acute Myeloid Leukemia, Multiple Myeloma
Website
gamida-cell.com neximmune.com
Gamida Cell Ltd. logo

About Gamida Cell Ltd.

Gamida Cell Ltd. is a biotechnology and healthcare company based in the United States. The company's slogan, "Working to turn cells into powerful therapeutics for patients with cancer," reflects its mission to revolutionize cell therapy for cancer treatment. Founded in 1998, Gamida Cell is a pioneer...

NexImmune, Inc. logo

About NexImmune, Inc.

NexImmune, Inc. is a publicly traded, clinical stage biotechnology company founded in 2011 and is making strides in the development of T cell immunotherapies through its propriety Artificial Immune Modulation (AIM™) technology. The company is focused on addressing unmet medical needs in oncology, sp...

We will tell you when either one moves

BounceWatch watches Gamida Cell Ltd. and NexImmune, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Gamida Cell Ltd. and NexImmune, Inc. — by email.

Frequently Asked Questions

Gamida Cell Ltd. — Working to turn cells into powerful therapeutics for patients with cancer. . NexImmune, Inc. — NexImmune, Directing T cell function to restore natural immunity. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Gamida Cell Ltd. has raised $292.51M while NexImmune, Inc. has raised $87.44M.
Gamida Cell Ltd. and NexImmune, Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Gamida Cell Ltd. with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Gamida Cell Ltd. on 12 Sep 2024, and NexImmune, Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy